
Read More
Biocon Ltd Concludes Rs 4,150 Crore Equity Fundraise through a Qualified In...
The shares of the company have a PE of 120x with just 40 per cent returns in just 2 years....

The shares of the company have a PE of 120x with just 40 per cent returns in just 2 years....

This marks a historic milestone as the first and only treatment approved in the United States for Me...